Skip to content

Clinical trials

Urologic Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urologic Diseases Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20121
20151
20171
20181
20201
20212
20222
20233
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Asan Medical Center2
Inje University2
Rainier Therapeutics2
Astellas Pharma Global Development, Inc.1
Ewha Womans University Mokdong Hospital1
HI-Bio, A Biogen Company1
Jade Biosciences, Inc.1
Medtronic1
Seoul National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urologic Diseases18
Kidney Diseases9
Glomerulonephritis, IGA7
Glomerulonephritis6
Renal Insufficiency, Chronic5
Carcinoma, Transitional Cell3
Renal Insufficiency3
Urinary Bladder Diseases3
Urinary Bladder Neoplasms3
Urogenital Diseases3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.